Effect of Vasodilator Therapy on Sympathetic Activity in Patients with Impaired Left Ventricular Function
暂无分享,去创建一个
A. Schömig | R. Dietz | W. Kübler | F. Schwarz | J. Manthey | H. Leinberger | E. Hackenthal | Y. Ke
[1] R. Gorlin,et al. Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure. , 1980, The New England journal of medicine.
[2] R. Gorlin,et al. Dose requirements of hydralazine in patients with severe chronic congestive heart failure. , 1980, The American journal of cardiology.
[3] J. Franciosa,et al. Immediate Effects of Hydralazine-Isosorbide Dinitrate Combination on Exercise Capacity and Exercise Hemodynamics in Patients with Left Ventricular Failure , 1979, Circulation.
[4] A. DeMaria,et al. Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy. , 1978, Archives of internal medicine.
[5] J. Cohn,et al. Vasodilator Therapy of Cardiac Failure , 1977 .
[6] M. da Prada,et al. Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. , 1976, Life sciences.
[7] E. Uhlich,et al. Radioimmunoassay of Arginine Vasopressin in Human Plasma* , 1975, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[8] E. Haber,et al. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. , 1969, The Journal of clinical endocrinology and metabolism.
[9] E. Braunwald,et al. F. SYMPATHETIC ACTIVITY AND NEUROTRANSMITTER DEPLETION IN CONGESTIVE HEART FAILURE , 1966 .